On September 26, 2023, Forte Biosciences Inc announced that it held its 2023 annual meeting of shareholders on September 19, 2023 and declared the voting results. Accordingly, a proposal submitted by ATG Capital Management LLC requesting the Company to amend the amended and restated bylaws was not approved by the shareholders of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.46 USD | -6.12% | -14.02% | -44.02% |
05-30 | Brookline Capital Initiates Forte Biosciences at Buy Rating With $4 Price Target | MT |
05-13 | Forte Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.02% | 16.76M | |
+16.45% | 122B | |
+21.96% | 116B | |
+24.19% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-16.52% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Declaration of Voting Results by Forte Biosciences